Low-dose aspirin therapy and periodontal attachment loss in ex- and non-smokers

Journal of Clinical Periodontology

Volumn 28, Issue 1, 2001, Pages 38-45

  Drouganis, Arthur ^a   Hirsch, Robert ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Aspirin; Periodontal attachment loss; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIODONTAL DISEASE; PERIODONTICS; QUESTIONNAIRE; SMOKING; SMOKING CESSATION; STATISTICAL MODEL; TOOTH PLAQUE;

AGED; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; DENTAL PLAQUE INDEX; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; QUESTIONNAIRES; SMOKING; SMOKING CESSATION;

EID: 0035219230     PISSN: 03036979     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-051x.2001.280106.x     Document Type: Article

References (45)

1. Alexander, M. B. & Damoulis, P. D. (1994) The role of cytokines in the pathogenesis of periodontal disease. Current Opinions in Periodontology 1, 39-53.
2. Bergström, J. & Preber, H. (1994) Tobacco use as risk factor. Journal of Periodontology 65, 545-550.
3. Brägger, U., Mühle, T., Fourmousis, I., Lang, N. P. & Mombelli, A. (1997) Effect of the NSAID fiurbiprofen on remodelling after periodontal surgery. Journal of Periodontal Research 32, 575-582.
4. Clària, J. & Serhan, C. N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proceedings of the National Academy of Sciences of the United States of America 92, 9475-9479.
5. Diener, H. C. (1998) Use of acetylsalicylic acid in secondary prevention of stroke. International Journal of Clinical Practice 52, 12-15.
6. Dziak, R. (1993) Biochemical and molecular mediators of bone metabolism. Journal of Periodontology 64, 407-415.
7. Feldman, R. S., Szeto, B., Chauncey, H. H. & Goldhaber, P. (1983) Non-Steroidal anti-inflammatory drugs in the reduction of human alveolar bone loss. Journal of Clinical Periodontology 10, 131-136.
8. Flemmig, T. F., Rumetsch, M. & Klaiber, B. (1996) Efficacy of systemically administered acetylsalicylic acid plus scaling on periodontal health and elastase-α-proteinase inhibitor in gingival crevicular fluid. Journal of Clinical Periodontology 23, 153-159.
9. Goultschin, J., Sgan-Cohen, H. D., Donchin, M. Brayer, L. & Soskolone, W.A. (1990) Associations of smoking with periotlontal treatment needs. Journal of Periodontology 61, 364-367.
10. Grossi, S. G., Genco, R. J. & Machtei, E. E. (1995) Assesment of risk for periodontal disease II. Risk indicators for alveolar bone loss. Journal of Periodontology 66, 23-29.
11. Grossi, S. A., Skrepcinski, F. B., DeCaro, T., Zambon, J. J., Cummins, D. & Genco, R. J. (1996) Response to periodontal therapy in diabetics and smokers. Journal of Periodontology 67, 1094-1102.
12. Grossi, S. G., Zambon, J., Machtei, E. E., Schifferle, R., Andreana, S., Genco, R. J., Cummins, D. & Harrap, G. (1997) Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. Journal of the American Dental Association 128, 599-607.
13. Haber, J., Wattles, J., Crowby, M. R. M., Joshipura, K. & Kent, R. L. (1993) Evidence for cigarette smoking as a major risk factor for periodontitis. Journal of Periodontology 64, 16-23.
14. Haffajee, A. D., Dibart, S., Kent, J. R. L. & Socransky, S. S. (1995) Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. Journal of Clinical Periodontology 22, 618-627.
15. Heasman, P. A., Offenbacher, S., Collins, J. G., Edwards, G. & Seymour, R. A. (1993) Flurbiprofen, in the prevention and treatment of experimental gingivitis. Journal of Clinical Periodontology 20, 732-738.
16. Heasman, P. A. & Seymour, R. A. (1989) The effect of a systemically administered non-steroidal anti-inflammatory drug (flurbiprofen) on experimental gingivitis in humans. Journal of Clinical Periodontology 16, 551-556.
17. Heasman, P. A. & Seymour, R. A. (1990) An association between long term non-steroidal anti-inflammatory drug therapy and the severity of periodontal disease. Journal of Clinical Periodontology 17, 654-658.
18. Heasman, P. A., Seymour, R. A. & Boston, P. F. (1989) The effect of a topical non-steroidal anti-inflammatory drug on the development of experimental gingivitis in man. Journal of Clinical Periodontology 16, 353-358.
19. Howell, T. H. & Williams, R. C. (1993) Non-steroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Critical Review in Oral Biology and Medicine 4, 177-196.
20. Ismail, M., Burt, B. A. & Eklund, S. A. (1983) Epidemiologic patterns of smoking and periodontal disease in the United States. Journal of the American Dental Association 106, 617-621.
21. Jeffcoat, M. K., Page, R., Reddy, M., Wannawissute, A., Waite, R, Palcanis, K., Cogen, R., Williams, R. C. & Basch, C. (1991) Use of digital radiography to demonstrate the potential of Naproxen as an adjunct in the treatment of rapidly progressive periodontitis. Journal of Periodontal Research 26, 415-421.
22. Jeffcoat, M. K., Reddy, M. S., Haigh, S., Buchanan, W., Doyle, M. J., Meredith, M. P., Nelson, S. L., Goodale, M. B. & Wehmeyer, K. R. (1995) A comparison of topical ketorolac, systemic fiurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. Journal of Pertodontology 66, 329-338.
23. Johnson, R. H., Armitage, G. C., Francisco, C. & Page, R. C. (1990) Assessment of the efficacy of a nonsteroidal antiinflammatory drug Naprosyn on the treatment of gingivitis. Journal of Periodontal Research 25, 230-235.
24. Kaldahl, W. B., Johnson, G. K., Patil, K. D. & Kalkwarf, K. L. (1996) Levels of cigarette consumption and response to periodontal therapy. Journal of Periodontology 67, 675-681.
25. MacGregor, I. D. M. (1992) Smoking and periodontal diseases. In: Drugs, diseases, and the periodontium, eds. Seymour, R.A., Heasman, P.A. & MacGregor, I.D.M., pp. 117-134. Oxford: Oxford University Press.
26. Meade, E. A., Smith, W. L. & DeWitt, D. L. (1993) Differential inhibition of prostaglandin enoperoxide synthetase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. Journal of Biological Chemistry 268, 6610-6614.
27. Mombelli, A., van Oosten, M. A. C., Schüren, E. & Lang, N. P. (1987) The microbiota associated with successful or failing implants. Oral Microbiology and Immunology 2, 145-151.
28. Nakashima, K., Roerich, N. & Cimasoni, G. (1994) Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. Journal of Clinical Periodontology 21, 327-333.
29. Ng, V. W. & Bissada, N. F. (1998) Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. Journal of Periodontology 69, 772-776.
30. Offenbacher, S., Heasman, P. A. & Collins, J. G. (1993) Modulation of host PGE2 secretion as a determinant of periodontal disease expression. Journal of Periodontology 64, 432-444.
31. Offenbacher, S., Odle, B. M. & Van Dyke, T. E. (1986) The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. Journal of Periodontal Research 21, 101-112.
32. Österberg, T. & Mellström, D. (1986) Tobacco smoking: a major risk factor for loss of teeth in three 70-year-old cohorts. Community Dentistry and Oral Epidemiology 14, 367-370.
33. Ruttimann, V E., de Valk, S. A., Engelke, W. H., Wright, W. E. & Cain, J. L. (1991) Effect of flurbiprofen in alveolar bone loss assessed by subtraction radiography. Journal of Dental Research 70 (special issue), abstr. #1616, 468.
34. Salvi, G. E., Lawrence, H. P., Offenbacher, S. & Beck, J. D. (1997) Influence of risk factors on the pathogenesis of periodontitis. Periodontology 2000 14, 173-201.
35. Schwartz, Z., Goultschin, J., Dean, D. D. & Boyan, B. D. (1997) Mechanisms of alveolar bone destruction in periodontitis. Periodontology 2000 14, 159-169.
36. Serhan, C. N. (1997) Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53, 107-137.
37. Silness, J. & Löe, H. (1964) Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica 24, 747-759.
38. Taiyeb, A. T. B. & Waite, I. M. (1993) The effect of systemic ibuprofen on gingival inflammation in humans. Journal of Clinical Periodontology 20, 723-728.
39. Underwood, M. J. (1994) The aspirin papers: Aspirin benefits patients with vascular disease and those undergoing revascularisation. British Medical Journal 308, 71-72.
40. Vane, J. & O'Grady, J. (1993) Therapeutic applications of prostaglandins. London: Edward Arnold,
41. Vogel, R. I., Copper, S. A., Schneider, L. G. & Goteiner, D. (1983) The effects of topical steroidal and systemic nonsteroidal anti-inflammatory drugs on experimental gingivitis in man. Journal of Periodontology 55, 247-251.
42. Waite, I. M., Saxton, C. A., Young, A., Wagg, B. J. & Corbel, M. (1981) The periodontal status of subjects receiving non-steroidal anti-inflammatory drugs. Journal of Periodontal Research 16, 100-108.
43. Wiebe, S. H., Hafezi, M., Sandhu, H. S., Sims, S. M. & Dixon, S. J. (1996) Osteoclast activation in inflammatory periodontal diseases. Oral Disease 2, 167-180.
44. Williams, R. C., Jeffcoat, M. K., Howell, H., Rolla, A., Stubbs, D., Teoh, K. O., Reddy, M. S. & Goldhaber, P. (1989) Altering the progression of human alveolar bone loss with non-steroidal anti-inflammatory drug flurbipofen. Journal of Periodontology 60, 485-490.
45. Zambon, J. J., Grossi, S. G., Machtei, E. E., Ho, A. W., Dunford, R. & Genco, R. J. (1996) Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. Journal of Periodontology 67, 1050-1054.